Anthropic priced its initial public offering at $83 per share ahead of an expected November 19 Nasdaq debut. Binance Wallet is running a separate xStocks campaign that gives eligible users access to tokenized price exposure tied to the AI company.
According to the official announcement, the campaign set an overall subscription cap of 500 million USDC. The application window ran on November 18, and the exchange scheduled distribution for at least two hours after the Nasdaq market opens.
How Anthropic xStocks fit alongside the IPO
Anthropic said the offering covers 980 million shares, worth $81.34 billion at the announced price. Anthropic is selling about 956.35 million shares. Existing shareholders are selling the remaining 23.65 million and will receive those proceeds. The shares are expected to trade under the ticker ANT.
The 500 million USDC figure is the maximum the wallet campaign said it could accept. It measures the size of the subscription program. The IPO figure comes from the number of shares in the Nasdaq offering and their price. Readers tracking the two figures should treat them as separate amounts.
What Binance Wallet participants should check
Binance Wallet describes the product as tokenized stock exposure and says participation depends on eligibility. The campaign takes place through the wallet. The issuer’s Nasdaq listing has its own schedule, ticker, offering documents, and customary closing conditions.
Timing matters for anyone tracking both products. Nasdaq trading was expected to start on November 19. The separate token distribution window starts at least two hours after the market opens. Anthropic expects the share offering to close on November 20, subject to customary conditions.
Tokenization has become a recurring part of Binance’s push into traditional markets. BlockBriefing previously covered seven tokenized equity and ETF pairs on Binance Spot. The wallet campaign adds an IPO-specific example of how exchanges are packaging exposure to public equities for eligible crypto users.
Anthropic’s pricing release also disclosed a 30-day option allowing underwriters to buy up to 147 million additional shares.
